Skip to main content

Is Tabrecta a chemotherapy drug?

Medically reviewed by Judith Stewart, BPharm. Last updated on Nov 24, 2022.

Official answer


Tabrecta (capmatinib) is a targeted chemotherapy drug. It differs from traditional chemotherapy drugs which attack all dividing cells, damaging healthy cells as well as cancerous ones.

Tabrecta is used to treat non-small cell lung cancer (NSCLC) that has spread (metastasized) in adults whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping.

Tabrecta targets NSCLC cells with a mutant MET gene lacking exon 14, which is a mutation associated with increased cancer cell growth. Tabrecta works by blocking the signals from these cells that drive the growth of cancer cells.


Read next

Related medical questions

Drug information

Related support groups